Lv3
360 积分 2023-05-10 加入
An iPSC-derived CD19/BCMA CAR-NK therapy in a patient with systemic sclerosis
5个月前
已完结
Induced pluripotent stem-cell-derived CD19-directed chimeric antigen receptor natural killer cells in B-cell lymphoma: a phase 1, first-in-human trial
5个月前
已完结
Two-layered immune escape in AML is overcome by Fcγ receptor activation and inhibition of PGE2 signaling in NK cells
5个月前
已完结
Enhancing anti-tumor immunity of natural killer cells through targeting IL-15R signaling
5个月前
已完结
Claudin-18 isoform 2-specific CAR T-cell therapy (satri-cel) versus treatment of physician's choice for previously treated advanced gastric or gastro-oesophageal junction cancer (CT041-ST-01): a randomised, open-label, phase 2 trial
6个月前
已完结
Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results
6个月前
已完结
[Chinese expert consensus of antibody-drug conjugate toxicity management for breast cancer]
6个月前
已完结
The hallmarks of cancer immune evasion
6个月前
已完结
Organoid Co-culture Methods to Capture Cancer Cell–Natural Killer Cell Interactions
7个月前
已完结
Cancer stem cell mimicry for immune evasion and therapeutic resistance
7个月前
已完结
皖公网安备34019202002308
